Akaoka Munetoshi, Haruki Koichiro, Yamahata Yuto, Okazaki Kohei, Furukawa Kenei, Tsunematsu Masashi, Shirai Yoshihiro, Onda Shinji, Matsumoto Michinori, Ikegami Toru
Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery The Jikei University School of Medicine Tokyo Japan.
Ann Gastroenterol Surg. 2024 Apr 16;8(5):917-926. doi: 10.1002/ags3.12804. eCollection 2024 Sep.
The cachexia index (CXI), which consists of skeletal muscle, inflammation, and nutritional status, has been associated with prognosis in patients with hepatocellular carcinoma (HCC). We hypothesized that dynamic changes in CXI might be associated with long-term outcomes in HCC.
This study comprised 131 patients who had undergone primary hepatic resection for HCC between 2008 and 2019. Preoperative CXI (pre-CXI) and postoperative CXI (post-CXI) were calculated by the following formula: skeletal muscle index x serum albumin level / neutrophil-to-lymphocyte ratio. Pre- and post-CXI were classified into two groups (high vs. low). We retrospectively investigated the association of perioperative dynamic changes in CXI with disease-free and overall survival.
In multivariate analyses, negative HBs-antigen ( = 0.02), high serum PIVKA-II level ( < 0.01), poor tumor differentiation ( = 0.02), multiple tumors ( < 0.01), microvascular invasion ( < 0.01), partial resection ( < 0.01), postoperative complications ( < 0.01), and low-pre-CXI ( < 0.01) were significant predictors of disease-free survival, while high ICG ( = 0.01), poor tumor differentiation ( < 0.01), multiple tumors ( = 0.01), postoperative complications ( < 0.01), low-pre-CXI ( < 0.01), and low-post-CXI ( < 0.01) were significant predictors of overall survival. Low-post-CXI was associated with older age ( = 0.045), larger tumor ( < 0.01), longer operation time ( = 0.047), greater intraoperative bleeding ( < 0.01), and intraoperative blood transfusion ( < 0.01). Moreover, dynamic changes in CXI were associated with overall survival in each subgroup of patients with low-pre-CXI ( = 0.02) or high-pre-CXI ( = 0.03).
Not only post-CXI but also dynamic changes in CXI from pre- to post-hepatectomy can be a prognostic indicator of HCC, providing a compelling rationale for aggressive perioperative nutritional and physical interventions to improve long-term outcomes.
恶病质指数(CXI)由骨骼肌、炎症和营养状况组成,已被证明与肝细胞癌(HCC)患者的预后相关。我们假设CXI的动态变化可能与HCC的长期预后相关。
本研究纳入了2008年至2019年间接受原发性肝癌肝切除手术的131例患者。术前CXI(pre-CXI)和术后CXI(post-CXI)通过以下公式计算:骨骼肌指数×血清白蛋白水平/中性粒细胞与淋巴细胞比值。将术前和术后CXI分为两组(高 vs. 低)。我们回顾性研究了围手术期CXI的动态变化与无病生存期和总生存期的关系。
在多因素分析中,乙肝表面抗原阴性(=0.02)、血清异常凝血酶原水平高(<0.01)、肿瘤分化差(=0.02)、多肿瘤(<0.01)、微血管侵犯(<0.01)、部分切除(<0.01)、术后并发症(<0.01)和术前CXI低(<0.01)是无病生存期的显著预测因素,而吲哚菁绿清除率高(=0.01)、肿瘤分化差(<0.01)、多肿瘤(=0.01)、术后并发症(<0.01)、术前CXI低(<头0.01)和术后CXI低(<0.01)是总生存期的显著预测因素。术后CXI低与年龄较大(=0.045)、肿瘤较大(<0.01)、手术时间较长(=0.047)、术中出血较多(<0.01)和术中输血(<0.01)相关。此外,术前CXI低(=0.02)或术前CXI高(=0.03)的各亚组患者中,CXI的动态变化与总生存期相关。
不仅术后CXI,而且肝切除术前至术后CXI的动态变化都可以作为HCC的预后指标,为积极的围手术期营养和身体干预以改善长期预后提供了有力的理论依据。